Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$50,921,611
+$1,587,057 QoQ
Shares Held
202,359
-10.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#356
of 4,153 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $505,465,921 across 15 Drug Manufacturers - General names. ABBV ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
138,183 | $165,740,842 | |
| 2 | JNJ |
Johnson & Johnson
|
348,850 | $88,597,425 | |
| 3 | MRK |
Merck & Co., Inc.
|
576,918 | $74,133,959 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
202,359 | $50,921,611 | |
| 5 | AMGN |
Amgen Inc
|
95,907 | $34,729,836 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
225,845 | $28,533,251 | |
| 7 | PFE |
Pfizer Inc
|
1,018,817 | $24,533,110 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
239,727 | $13,813,066 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,921,611 | 202,359 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $49,334,554 | 226,836 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $33,922,073 | 148,462 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $31,504,949 | 136,067 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $22,031,604 | 118,692 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $22,968,837 | 109,626 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $17,268,527 | 97,178 | Shares | Other | 2025-01-28 | |
| 2024-09-30 | $16,044,063 | 81,244 | Shares | Other | 2024-11-06 | |
| 2024-06-30 | $15,540,566 | 90,605 | Shares | Other | 2024-07-30 | |
| 2024-03-31 | $8,194,314 | 44,999 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $12,023,035 | 77,583 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $10,306,752 | 69,145 | Shares | Other | 2023-11-01 | |
| 2023-06-30 | $3,071,438 | 22,797 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $3,621,681 | 22,725 | Shares | Other | 2023-04-05 | |
| 2022-12-31 | $3,092,728 | 19,137 | Shares | Other | 2023-02-21 | |
| 2022-09-30 | $1,132,194 | 8,436 | Shares | Other | 2022-11-04 | |
| 2022-06-30 | $2,856,433 | 18,650 | Shares | Other | 2022-08-01 | |
| 2022-03-31 | $975,902 | 6,020 | Shares | Other | 2022-04-21 | |
| 2021-12-31 | $786,403 | 5,808 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $544,204 | 5,045 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $319,446 | 2,836 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||